Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Comparison of sulfide-oxidizing Sulfurimonas strains reveals a new mode of thiosulfate formation in subsurface environments.

Lahme S, Callbeck CM, Eland LE, Wipat A, Enning D, Head IM, Hubert CRJ.

Environ Microbiol. 2019 Dec 15. doi: 10.1111/1462-2920.14894. [Epub ahead of print]

PMID:
31840396
2.

Long-Term Results after Surgical Treatment of Congenital Penile Curvature Using a Modified Nesbit Technique.

Sokolakis I, Schönbauer P, Mykoniatis I, Kübler H, Gschwend J, Lahme S, Hatzichristodoulou G.

World J Mens Health. 2019 Sep 4. doi: 10.5534/wjmh.190092. [Epub ahead of print]

3.

Metabolites of an Oil Field Sulfide-Oxidizing, Nitrate-Reducing Sulfurimonas sp. Cause Severe Corrosion.

Lahme S, Enning D, Callbeck CM, Menendez Vega D, Curtis TP, Head IM, Hubert CRJ.

Appl Environ Microbiol. 2019 Jan 23;85(3). pii: e01891-18. doi: 10.1128/AEM.01891-18. Print 2019 Feb 1.

4.

No evidence for point mutations in the novel renal cystine transporter AGT1/SLC7A13 contributing to the etiology of cystinuria.

Olschok K, Vester U, Lahme S, Kurth I, Eggermann T.

BMC Nephrol. 2018 Oct 20;19(1):278. doi: 10.1186/s12882-018-1080-5.

5.

Miniaturisation of PCNL.

Lahme S.

Urolithiasis. 2018 Feb;46(1):99-106. doi: 10.1007/s00240-017-1029-3. Epub 2017 Dec 14. Review.

PMID:
29243096
6.

European Association of Urology Section of Urolithiasis (EULIS) Consensus Statement on Simulation, Training, and Assessment in Urolithiasis.

Ahmed K, Patel S, Aydin A, Veneziano D, van Cleynenbreugel B, Gözen AS, Skolarikos A, Sietz C, Lahme S, Knoll T, Redorta JP, Somani BK, Sanguedolce F, Liatsikos E, Rassweiler J, Khan MS, Dasgupta P, Sarica K.

Eur Urol Focus. 2018 Jul;4(4):614-620. doi: 10.1016/j.euf.2017.03.006. Epub 2017 Mar 31.

PMID:
28753871
7.

Update of the ICUD-SIU consultation on stone technology behind ureteroscopy.

Cloutier J, Anson K, Giusti G, Grasso M, Kamphuis G, Lahme S, Liatsikos E, Patel A, Pearle MS, Valiquette L, Traxer O.

World J Urol. 2017 Sep;35(9):1353-1359. doi: 10.1007/s00345-017-2073-x. Epub 2017 Jul 25. Review.

PMID:
28744695
8.

Signal-to-noise in femtosecond electron diffraction.

Kealhofer C, Lahme S, Urban T, Baum P.

Ultramicroscopy. 2015 Dec;159 Pt 1:19-25. doi: 10.1016/j.ultramic.2015.07.004. Epub 2015 Jul 22.

PMID:
26241301
9.

Benzoate mediates the simultaneous repression of anaerobic 4-methylbenzoate and succinate utilization in Magnetospirillum sp. strain pMbN1.

Lahme S, Trautwein K, Strijkstra A, Dörries M, Wöhlbrand L, Rabus R.

BMC Microbiol. 2014 Oct 27;14:269. doi: 10.1186/s12866-014-0269-4.

10.

Femtosecond single-electron diffraction.

Lahme S, Kealhofer C, Krausz F, Baum P.

Struct Dyn. 2014 Jun 24;1(3):034303. doi: 10.1063/1.4884937. eCollection 2014 May.

11.

[Prof. Dr. Karl-Horst Bichler on the occasion of his 80th birthday].

Flüchter SH, Strohmaier WL, Wechsel HW, Lahme S.

Urologe A. 2014 Feb;53(2):249-52. doi: 10.1007/s00120-013-3405-0. German. No abstract available.

PMID:
24458136
12.

Stone-free rate (SFR): a new proposal for defining levels of SFR.

Somani BK, Desai M, Traxer O, Lahme S.

Urolithiasis. 2014 Apr;42(2):95. doi: 10.1007/s00240-013-0630-3. Epub 2013 Dec 7.

PMID:
24317839
13.

Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study.

Hatzichristodoulou G, Meisner C, Gschwend JE, Stenzl A, Lahme S.

J Sex Med. 2013 Nov;10(11):2815-21. doi: 10.1111/jsm.12275. Epub 2013 Jul 30.

PMID:
23898925
14.

Surgical therapy of Peyronie's disease by partial plaque excision and grafting with collagen fleece: feasibility study of a new technique.

Hatzichristodoulou G, Gschwend JE, Lahme S.

Int J Impot Res. 2013 Sep;25(5):183-7. doi: 10.1038/ijir.2013.7. Epub 2013 Feb 28.

PMID:
23446807
15.

Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication.

Degrandi D, Kravets E, Konermann C, Beuter-Gunia C, Klümpers V, Lahme S, Wischmann E, Mausberg AK, Beer-Hammer S, Pfeffer K.

Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):294-9. doi: 10.1073/pnas.1205635110. Epub 2012 Dec 17.

16.

Physiological and proteomic adaptation of "Aromatoleum aromaticum" EbN1 to low growth rates in benzoate-limited, anoxic chemostats.

Trautwein K, Lahme S, Wöhlbrand L, Feenders C, Mangelsdorf K, Harder J, Steinbüchel A, Blasius B, Reinhardt R, Rabus R.

J Bacteriol. 2012 May;194(9):2165-80. doi: 10.1128/JB.06519-11. Epub 2012 Feb 24.

17.

Anaerobic degradation of 4-methylbenzoate via a specific 4-methylbenzoyl-CoA pathway.

Lahme S, Eberlein C, Jarling R, Kube M, Boll M, Wilkes H, Reinhardt R, Rabus R.

Environ Microbiol. 2012 May;14(5):1118-32. doi: 10.1111/j.1462-2920.2011.02693.x. Epub 2012 Jan 20.

PMID:
22264224
18.

Anaerobic degradation of 4-methylbenzoate by a newly isolated denitrifying bacterium, strain pMbN1.

Lahme S, Harder J, Rabus R.

Appl Environ Microbiol. 2012 Mar;78(5):1606-10. doi: 10.1128/AEM.06552-11. Epub 2011 Dec 16.

19.

Stereochemical investigations reveal the mechanism of the bacterial activation of n-alkanes without oxygen.

Jarling R, Sadeghi M, Drozdowska M, Lahme S, Buckel W, Rabus R, Widdel F, Golding BT, Wilkes H.

Angew Chem Int Ed Engl. 2012 Feb 6;51(6):1334-8. doi: 10.1002/anie.201106055. Epub 2011 Nov 30. No abstract available.

PMID:
22127985
20.

Co-metabolic conversion of toluene in anaerobic n-alkane-degrading bacteria.

Rabus R, Jarling R, Lahme S, Kühner S, Heider J, Widdel F, Wilkes H.

Environ Microbiol. 2011 Sep;13(9):2576-86. doi: 10.1111/j.1462-2920.2011.02529.x. Epub 2011 Aug 22.

PMID:
21880102
21.

Laparoscopic adrenalectomy in urological centres - the experience of the German Laparoscopic Working Group.

Greco F, Hoda MR, Rassweiler J, Fahlenkamp D, Neisius DA, Kutta A, Thüroff JW, Krause A, Strohmaier WL, Bachmann A, Hertle L, Popken G, Deger S, Doehn C, Jocham D, Loch T, Lahme S, Janitzky V, Gilfrich CP, Klotz T, Kopper B, Rebmann U, Kälbe T, Wetterauer U, Leitenberger A, Rassler J, Kawan F, Inferrera A, Wagner S, Fornara P.

BJU Int. 2011 Nov;108(10):1646-51. doi: 10.1111/j.1464-410X.2010.10038.x. Epub 2011 Apr 6.

22.

Stones of the upper urinary tract. Update on minimal-invasive endourological treatment.

Lahme S, Zimmermanns V, Hochmuth A, Liske P.

Arch Ital Urol Androl. 2008 Mar;80(1):13-7.

PMID:
18533619
23.

[Minimally invasive PCNL (mini-perc). Alternative treatment modality or replacement of conventional PCNL?].

Lahme S, Zimmermanns V, Hochmuth A, Janitzki V.

Urologe A. 2008 May;47(5):563-8. doi: 10.1007/s00120-008-1708-3. German.

PMID:
18373077
24.

Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.

Siemer S, Lahme S, Altziebler S, Machtens S, Strohmaier W, Wechsel HW, Goebell P, Schmeller N, Oberneder R, Stolzenburg JU, Becker H, Lüftenegger W, Tetens V, Van Poppel H.

Eur Urol. 2007 Oct;52(4):1156-63. Epub 2007 Apr 18.

PMID:
17467884
25.

Shockwave lithotripsy and endourological stone treatment in children.

Lahme S.

Urol Res. 2006 Apr;34(2):112-7. Epub 2006 Jan 31. Review.

PMID:
16446980
26.

Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.

Straub M, Strohmaier WL, Berg W, Beck B, Hoppe B, Laube N, Lahme S, Schmidt M, Hesse A, Koehrmann KU.

World J Urol. 2005 Nov;23(5):309-23. Epub 2005 Nov 29. Review.

PMID:
16315051
27.

Functional analysis of a new splice site mutation, c.605-3C>A, in the cystinuria gene SLC7A9 leading to exon skipping.

Schmidt C, Lahme S, Zerres K, Eggermann T.

Mol Genet Metab. 2005 Feb;84(2):172-5.

PMID:
15670723
28.

[Therapy options in lower kidney calix calculus].

Lahme S, Köhrmann KU.

Aktuelle Urol. 2004 Apr;35(2):98-101; discussion 101-2. German. No abstract available.

PMID:
15264135
29.

Comparison of cytology and nuclear matrix protein 22 (NMP 22) for the detection and follow-up of bladder-cancer.

Lahme S, Bichler KH, Feil G, Zumbrägel A, Götz T.

Adv Exp Med Biol. 2003;539(Pt A):111-9.

PMID:
15088900
30.

Renal tubular alteration by crystalluria in stone disease-an experimental study by means of MDCK cells.

Lahme S, Feil G, Strohmaier WL, Bichler KH, Stenzl A.

Urol Int. 2004;72(3):244-51.

PMID:
15084771
31.

The population-specific distribution and frequencies of genomic variants in the SLC3A1 and SLC7A9 genes and their application in molecular genetic testing of cystinuria.

Schmidt C, Vester U, Hesse A, Lahme S, Lang F, Zerres K, Eggermann T; Arbeitsgemeinschaft Pädiatrische Nephrologie.

Urol Res. 2004 May;32(2):75-8. Epub 2004 Feb 26.

PMID:
14991253
32.

Stimulation of renal Na+ dicarboxylate cotransporter 1 by Na+/H+ exchanger regulating factor 2, serum and glucocorticoid inducible kinase isoforms, and protein kinase B.

Boehmer C, Embark HM, Bauer A, Palmada M, Yun CH, Weinman EJ, Endou H, Cohen P, Lahme S, Bichler KH, Lang F.

Biochem Biophys Res Commun. 2004 Jan 23;313(4):998-1003.

PMID:
14706641
33.

Significant contribution of genomic rearrangements in SLC3A1 and SLC7A9 to the etiology of cystinuria.

Schmidt C, Vester U, Wagner CA, Lahme S, Hesse A, Hoyer P, Lang F, Zerres K, Eggermann T; Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Kidney Int. 2003 Nov;64(5):1564-72.

34.

[Treatment of urolithiasis].

Bichler KH, Eipper E, Götz T, Lahme S, Hohneder A.

Med Monatsschr Pharm. 2003 Aug;26(8):272-7. Review. German. No abstract available.

PMID:
12953380
35.

Genetic variations of the SLC7A9 gene: allele distribution of 13 polymorphic sites in German cystinuria patients and controls.

Schmidt C, Tomiuk J, Botzenhart E, Vester U, Halber M, Hesse A, Wagner C, Lahme S, Lang F, Zerres K, Eggermann T, Bachmann H, Bökenkamp A, Fischbach M, Fründ S, Pistor KG, Zappel HF; APN Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Clin Nephrol. 2003 May;59(5):353-9.

PMID:
12779097
36.

Genomic and functional investigations of mutations of the SLC3A1 gene in cystinuria.

Lahme S, Bichler KH, Eggermann T, Lang F.

Urol Int. 2002;69(3):207-11.

PMID:
12372889
37.

Urinary infection stones.

Bichler KH, Eipper E, Naber K, Braun V, Zimmermann R, Lahme S.

Int J Antimicrob Agents. 2002 Jun;19(6):488-98. Review.

PMID:
12135839
38.

Collagen fleece for defect coverage following plaque excision in patients with Peyronie's disease.

Lahme S, Götz T, Bichler KH.

Eur Urol. 2002 Apr;41(4):401-5.

PMID:
12074811
39.

Analysis of the genes SLC7A9 and SLC3A1 in unclassified cystinurics: mutation detection rates and association between variants in SLC7A9 and the disease.

Schmidt C, Albers A, Tomiuk J, Eggermann K, Wagner C, Capasso G, Lahme S, Hesse A, Lang F, Zerres K, Eggermann T.

Clin Nephrol. 2002 May;57(5):342-8.

PMID:
12036192
40.

Selenium reduces high energy shock wave-induced renal injury in rats.

Strohmaier WL, Billes IC, Abelius A, Lahme S, Bichler KH.

Urol Res. 2002 Mar;30(1):31-4.

PMID:
11942323
41.

[Molecular biology of cystinuria].

Albers A, Wagner CA, Schmidt C, Lahme S, Bichler KH, Lang F, Zerres K, Eggermann T.

Fortschr Med Orig. 2001;119(1):49-50. German.

PMID:
11935659
42.

Minimally invasive PCNL in patients with renal pelvic and calyceal stones.

Lahme S, Bichler KH, Strohmaier WL, Götz T.

Eur Urol. 2001 Dec;40(6):619-24.

PMID:
11805407
43.

Comparison of cytology and nuclear matrix protein 22 for the detection and follow-up of bladder cancer.

Lahme S, Bichler KH, Feil G, Krause S.

Urol Int. 2001;66(2):72-7.

PMID:
11223747
44.
45.

Reduction of high-energy shock-wave-induced renal tubular injury by selenium.

Strohmaier WL, Lahme S, Weidenbach PM, Bichler KH.

Urol Res. 1999 Oct;27(5):382-5.

PMID:
10550528
46.

Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)?

Wechsel HW, Feil G, Lahme S, Zumbragel A, Petri E, Bichler KH.

Anticancer Res. 1999 Jul-Aug;19(4A):2577-81.

PMID:
10470198
47.

Mutations in the SLC3A1 gene in cystinuric patients: frequencies and identification of a novel mutation.

Albers A, Lahme S, Wagner C, Kaiser P, Zerres K, Capasso G, Pica A, Palacin M, Lang F, Bichler KH, Eggermann T.

Genet Test. 1999;3(2):227-31.

PMID:
10464673
48.

Renal cell carcinoma: relevance of angiogenetic factors.

Wechsel HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E.

Anticancer Res. 1999 Mar-Apr;19(2C):1537-40.

PMID:
10365140
49.

[Collagen metabolism in induratio penis plastica (IPP)].

Bichler KH, Lahme S, Mattauch W, Petri E.

Urologe A. 1998 May;37(3):306-11. German.

PMID:
9646430
50.

[Significance of "clinically insignificant residual fragments" (CIRF) after ESWL].

Lahme S, Wilbert DM, Bichler KH.

Urologe A. 1997 May;36(3):226-30. German.

PMID:
9265342

Supplemental Content

Support Center